Jang, Tyng-Yuan
Wei, Yu-Ju
Liu, Ta-Wei
Yeh, Ming-Lun
Liu, Shu-Fen
Hsu, Cheng-Ting
Hsu, Po-Yao
Lin, Yi-Hung
Liang, Po-Cheng
Hsieh, Meng-Hsuan
Ko, Yu-Min
Tsai, Yi-Shan
Chen, Kuan-Yu
Lin, Ching-Chih
Tsai, Pei-Chien
Wang, Shu-Chi
Huang, Ching-I.
Lin, Zu-Yau
Chen, Shinn-Cherng
Chuang, Wan-Long
Huang, Jee-Fu
Dai, Chia-Yen
Huang, Chung-Feng
Yu, Ming-Lung
Article History
Received: 3 August 2020
Accepted: 30 March 2021
First Online: 14 April 2021
Competing interests
: Ming-Lung Yu: Research support (grant) from Abbott, BMS, Gilead, and Merck. Consultant of Abbvie, Abbott, BMS, Gilead, Merck and Roche. Speaker of Abbvie, Abbott, BMS, Gilead, Merck, and IPSEN. Chung-Feng Huang: Speaker of Gilead, Abbie, Merck and BMS. Other authors share no competing interests.